Alternative techniques to the traditional plasma exchange are emerging in clinical practice for the treatment of different pathological conditions, particularly autoimmune diseases. Filtration is a technique used to separate blood cells from plasma, which may be further “treated” with other filters or columns. The case for cascade filtration and absorption onto a column is becoming stronger and stronger and the patient population is increasing. Alongside the “historical” techniques of adsorption onto a column, new systems (pairs of self-regenerating columns) and new products (columns with dextran sulphate, tryptophane, anti-human lipoprotein antibodies) are now available. Protein A in particular seems to open up new horizons; in therapeutic plasmapheresis, there are two versions, one Swedish and the other American, based on different theoretical premises and obtaining different results, with different biocompatibilities but good clinical results.
BesingerW.I., BakerD.A., BucknerC.D., CliftR.A., ThomasE.D.Immunoadsorption for removal of A and B blood-group antibodies.N Engl J Med1981; 304: 160–2.
3.
TermanD.S., BuffaloeG., MattioliE.Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.Lancet1979; 2: 824–6.
4.
MarcusL., Margel5, SavinH., OffarimM., RavidM.Therapy of digoxin intoxication in dogs by specific hemoperfusion through agarose polyacrolein microsphere beads.Am Heart J1985; 110: 30–9.
5.
StoffelY., BorbergH., GreveV.Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.Lancet1981; ii: 1005–7.
6.
StoffelW., DemantT.Selective removal of apolipoprotein B- containing serum lipoproteins from blood plasma.Proc Natl Acad Sci USA1981; 78: 611–5.
7.
BorbergH., StoffelY., OetteK.The development of specific plasma immunoadsorption.Plasma Ther Transfus Transfus Technol1983; 4: 459 -66.
8.
BorbergH., GaczkowskiA., HombachV., OetteK., StoffelY.Treatment of familiar hypercholesterolemia by means of specific immunoadsorption.J Clin Apheresis1988; 4: 58–65.
9.
BorbergH., KadarJ., OetteK.The current status of low density lipoprotein apheresis. In: NedeggerU.E., ed. Therapeutic hemapheresis in the 1990 s. Curr. Stud. Hematol. Blood Transf. Basel: Karger1990, N° 57.
10.
OrekhovA.N., KhaizullaA., PokrovskyS.N.Low-density Lipoprotein apheresis and regression of atherosclerotic plaque in vitro.Artificial Organs1986; 10(6): 466–9.
11.
PokrovskyS.N., AdamovaI.Y., AfanasievaO.Y.Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study.Artificial Organs1991; 15(2): 136–46.
12.
ThompsonG.R., LowenthalR.N., MyantB.Plasma exchange in the management of homozygous familial hypercholesterolaemia.Lancet1975; i: 1208–11.
13.
SomeJ., SaibaraT., HimenoH.Assessment of bilirubin clearance capacity of a newly developed ion exchange adsorption column and its possible use as a supportive therapy in hepatorenal syndrome.Jour of Clin Apher1990; 5: 123–7.
14.
YokoyamaS., YamamotoA.Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis.Arteriosclerosis1984; 4: 276–82.
15.
YokoyamaS., YamamotoA.Selective removal of low-density-lipoprotein by plasmapheresis in familial hypercholesterolemia.Arteriosclerosis1985; 5: 613–22.
16.
BusnachG., BaggioG., ScarpatoN., StefanuttiC. In: Gotto, ed. Treatment of severe hypercholesterolemia in the prevention of coronary heart disease.Basel: Karger1988.
17.
YamazakiZ., FujimoriY., TakahamaT.Efficiency and biocompatibility of a new immunosorbent.Trans Am Soc Artif Intern Organs1982; 28: 318–23.
18.
SatoT., NishimuyaJ., AraiK.Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunosorbent. In: OdaT., ed. Therapeutic Plasmapheresis III.Stuttgart: Schattauer, 1983; pp. 565–8.
19.
HbiningerK., EndricksM., ToykaK.V.Myasthenia gravis a new semiselective procedure to remove acetylcholine receptor autoantibodies for plasma.Plasma Ther Transfus Technol1985; 6: 771–5.
20.
HbiningerK., HartungH.P., ToykaK.V.Therapeutic plasma exchange in myasthenia gravis: semiselective adsorption of anti-A ChR autoantibodies with tryptophan-linked polyvinylalcohol gels.Ann NY Acad Sci1987; 505: 898–900.
21.
AvanziG., MarconiG.Semiselective immunoadsorption of anti A ChR abs. on tryptophan column in Myasthenia Gravis. Clinical experience in 32 patients.Transfus Sci1993; 14: 17–21.
22.
BansalS.C., BansalB.R., ThomasH.R.Ex vivo removal of serum IgG in a patient with colon carcinoma.Cancer1978; 42: 1–18.
23.
TermanD.S., YoungJ.B., ShearerY.T.Preliminary observation of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A.N Engl J Med1981; 305: 1195–20.
24.
KorecS., SmithF.P., ScheinP.S., PhillipsT.Clinical experiences with plasmaperfusion over staph protein A filters in cancer patients.J Biol Response Mbd1984; 3: 365–9.
25.
KorecS., SheinP.S., SmithF.P.Treatment of cancer-associated hemolytic-uremic syndrome with staphylococcal protein A immunoperfusion.J Clin Oncol1986; 4: 210–5.
26.
JonesF.R., BalinJ.P.Jr., SnyderH.Y.Jr., the Prosorba Column Clinical Trial Group. Selective extracorporeal removal of immunoglobulin-G and circulating immune complexes: a review.Plasma Ther Transfus Technol1986; 7: 333–49.
27.
SnyderH.W., HbnryD.H.Minimal toxicity during Protein A immunoadsorption treatment of malignant disease. An outpatient therapy.J Clin Apher1991; 6: 1–10.
28.
SnyderH.W., CochranS.K.Experience with protein A immunoadsorption in treatment resistant adult immune thrombocytopenic purpura.Blood1992; 79: 2237–45.
29.
NilssonI.M., JonssonS., SundqvistS.B., AhlbergA., and Ber-gentzS.E.A procedure for removing high titer antibodies by extracorporeal protein A-Sepharose adsorption in hemophilia: Substitution therapy and surgery in a patient with hemophilia B and antibodies.Blood1981; 58: 38–44.
30.
NilssonI.M., FreiburghausC., SundqvistS.B., and SandbergH.Removal of specific antibodies from whole blood in a continuous extracorporeal system.Plasma Ther Transfus Technol1984; 5: 127–31.
31.
PalmerA., TaubeD.Removal of anti HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.The Lancet January 7, 1989.
